Tag: Public Health

Muniaraj Mayilsamy, Public Health, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Muniaraj Mayilsamy, Public Health, Best Researcher Award

Dr. Muniaraj Mayilsamy: Scientist E at ICMR-Vector Control Research Centre, India

 

Title/Designation: Dr.
Name: Muniaraj Mayilsamy
Current Role/Designation: Scientist E
Organization/Institution Details: ICMR-Vector Control Research Centre
Country: India
Subject Track: Public Health
Award Category: Best Researcher Award

Dr. Muniyaraj Mayilsamy is a distinguished Scientist “E” at the ICMR-Vector Control Research Centre (VCRC), Field Station, Madurai, and serves as an Associate Professor with the Academy of Scientific and Innovative Research (AcSIR). With over 30 years of experience in academia and public health research, he has made significant contributions in the fields of microbiology, medical entomology, and vector-borne disease surveillance and control. His work bridges classical microbiology with modern biotechnological approaches to vector control, focusing on microbial diversity, insect-microbe interactions, and novel bio-control strategies. He has been instrumental in conceptualizing and executing innovative projects involving gnotobiotic mosquitoes, mosquito attractants, and microbial larvicides, and has trained numerous students and professionals in vector biology and disease control. His research impact extends both nationally and internationally through his publications, patents, and speaking engagements.

Online Profiles

ORCID Profile

Education

Dr. Muniyaraj holds a Ph.D. in Zoology from Madurai Kamaraj University, where his research explored the role of Philodina roseola in mosquito breeding ecology. His academic journey includes an M.Sc. in Microbiology from the same university, where he secured the first rank and a gold medal for his outstanding performance. He also holds a Postgraduate Diploma in Intellectual Property Rights and Patent Laws from Annamalai University, and a diploma in Computer Applications, reflecting his multidisciplinary skill set. His foundational education in Zoology during his undergraduate years provided him with a strong grounding in biological sciences, sericulture, and applied microbiology, forming the basis for his career in vector biology and microbial research.

Research Focus

Dr. Muniyaraj’s research focuses on the microbial ecology of disease vectors, the symbiotic and antagonistic relationships between insects and microbes, and the development of novel, eco-friendly vector control tools. His work spans across the discovery of mosquito attractants from human skin bacteria, application of nanotechnology for microbial larvicide delivery, and innovations such as devices for producing germ-free and gnotobiotic mosquitoes. He is particularly interested in how microbial communities influence mosquito biology and pathogen transmission, and how these interactions can be harnessed to develop sustainable and cost-effective strategies for the control of vector-borne diseases such as malaria, dengue, chikungunya, and Japanese encephalitis.

Experience

Over the past three decades, Dr. Muniyaraj has served in progressively responsible roles across multiple ICMR institutes, including CRME and VCRC, beginning as a Research Officer and ascending to Scientist “E”. He has also served as Officer-in-Charge for several field stations and played a pivotal role in both research and administrative management. Prior to joining ICMR, he held academic positions as Lecturer and Head of the Department of Microbiology in leading Tamil Nadu colleges. His career reflects a rare combination of field expertise, academic leadership, laboratory innovation, and administrative proficiency. He has contributed significantly to national vector surveillance programs, outbreak investigations, and translational research in disease control, while also mentoring postgraduates and Ph.D. scholars.

Research Timeline & Activities

Dr. Muniyaraj has successfully led and participated in numerous research projects funded by ICMR, DST, and DRDO from 2009 onwards. His recent projects include studies on bacterial metabolites as mosquito attractants, nanofibre-based larvicide delivery, and investigations on viral persistence in aquatic microfauna. His pioneering invention of devices for generating germ-free mosquitoes received international patents in India, Singapore, and Indonesia. He has been a key figure in dengue, JE, and Zika surveillance studies, and served as a team leader in COVID-19 diagnostic efforts in Pondicherry. His academic service includes teaching postgraduate courses, delivering lectures in refresher programs, serving on university boards, and acting as a doctoral committee member across universities. He is also a frequent invited speaker and resource person in national and international seminars.

Awards & Honors

Dr. Muniyaraj has been widely recognized for his academic excellence and scientific contributions. He received the University First Rank and Gold Medal for his M.Sc. Microbiology, and was awarded the Best Citizen of India Award and Bharat Jyoti Award in 2013. His work has earned international recognition, including selection as one of the “Top 100 Scientists of 2009” and the “International Einstein Award for Scientific Achievement” from the International Biographical Centre, Cambridge. He has been included in Marquis Who’s Who in Asia and the World, reflecting his prominence in global scientific circles. He has also received multiple best poster awards at prestigious symposia and has been an editorial board member and reviewer for numerous international journals.

Top Noted Publication

Among his 45+ peer-reviewed publications, a particularly notable work is the 2025 article in Nature Scientific Reports, titled “Nanofiber encapsulation of Pseudomonas aeruginosa for the sustained release of mosquito larvicides.” This high-impact paper (IF 3.8) highlights his interdisciplinary approach combining microbiology, entomology, and nanotechnology to develop environmentally safe and effective larvicidal strategies. The study demonstrated how microbial bioagents can be engineered for prolonged field efficacy, offering a potential breakthrough in vector control efforts. This work is widely cited and has received attention from both academic and public health communities for its innovative application in disease prevention.

  • Nanofiber encapsulation of Pseudomonas aeruginosa for the sustained release of mosquito larvicides
    Scientific Reports, 2025
    DOI: 10.1038/S41598-025-97400-W
    Contributors: Muniaraj M, Asifa V, Rajamannar V, Ganakumar G, Paramasivan R

  • ZIKA Virus, an Emerging Arbovirus in India: A Glimpse of Global Genetic Lineages
    Microorganisms, 2025
    DOI: 10.3390/MICROORGANISMS13030544
    Contributors: Paramasivan R, Bhavna Gupta, Muniaraj M

  • Genome resequencing and genome-wide polymorphisms in mosquito vectors Aedes aegypti and Aedes albopictus from south India
    Scientific Reports, 2024
    DOI: 10.1038/S41598-024-71484-2
    Contributors: Preeti Acharya, Upasana S. Singh, Rajamannar V, Muniaraj M, Binata Nayak, Aparup Das

  • Rising case-fatality rate of kala-azar (visceral leishmaniasis) in India: An unexpected challenge to the kala-azar elimination program?
    Tropical Parasitology, 2024
    DOI: 10.4103/TP.TP_57_23
    Contributors: Muniaraj M, Rajamannar V, Paramasivan R

  • Mosquito repellent activities of citrus fruit peels
    International Journal of Mosquito Research, 2023
    DOI: 10.22271/23487941.2023.V10.I5B.702
    Contributors: Jeevarathinam Antony, Asifa V, Arthi M, Rajamannar V, Muniaraj M

Strengths for the Best Researcher Award

  1. Extensive and Diverse Research Experience:
    Dr. Muniaraj Mayilsamy brings over 30 years of progressive experience in public health research, specializing in microbiology, medical entomology, and vector-borne disease control. His long-standing commitment and leadership in both laboratory and field research have produced impactful outcomes in the study and management of disease vectors.

  2. Innovative and Interdisciplinary Approaches:
    His pioneering work integrates classical microbiology with cutting-edge biotechnology and nanotechnology, particularly in the development of novel vector control tools such as microbial larvicides and germ-free mosquito models. This interdisciplinary approach has resulted in international patents and high-impact publications, reflecting innovation that advances the field.

  3. National and International Recognition:
    Dr. Muniaraj’s contributions have been recognized globally, earning him prestigious awards such as the “International Einstein Award for Scientific Achievement” and inclusion in Marquis Who’s Who. His research has influenced vector control strategies not only in India but also in broader scientific and public health communities worldwide.

  4. Strong Academic and Mentorship Record:
    Beyond research, he has actively contributed to academia as an Associate Professor, training numerous students and professionals in vector biology and public health. His mentorship has helped cultivate the next generation of researchers and practitioners in vector control and epidemiology.

  5. Consistent Research Output and Impact:
    With over 45 peer-reviewed publications, including influential recent works on mosquito larvicides and viral vector genetics, Dr. Muniaraj has demonstrated sustained productivity and research excellence. His studies have practical implications for controlling diseases like malaria, dengue, chikungunya, and Zika, showcasing both scientific rigor and public health relevance.

Shyam Prakash, Public Health, Healthcare Innovation Award

Posted on by scizentox scizentoxLeave a Comment on Shyam Prakash, Public Health, Healthcare Innovation Award

Dr. Shyam Prakash: Prof ( Additional) at All India Institute of Medical Science, Ansari Nagar, New Delhi, India

Dr. Shyam Prakash is a senior biomedical researcher and Additional Professor at the Department of Laboratory Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi. With over 30 years of experience in clinical biochemistry and molecular diagnostics, he has established himself as a leading expert in the field of gastrointestinal, hepatic, and metabolic diseases. His translational research focuses on bridging laboratory science with patient care through the development of innovative diagnostic tools, point-of-care technologies, and molecular markers for early disease detection. Throughout his career, he has contributed significantly to public health research, diagnostics, and academic mentorship, mentoring over 22 MD and PhD students and authoring 75+ research papers.

Online Profiles

Google Scholar Profile

Citation Metrics

As of 2025, Dr. Shyam Prakash has received a total of 2,726 citations, with 1,021 citations since 2020. His h-index stands at 26, indicating substantial impact and consistent contributions across multiple publications. Additionally, his i10-index is 67, with 28 publications having received 10 or more citations since 2020. These metrics reflect the relevance and reach of his research in clinical biochemistry, molecular diagnostics, and translational medicine.

Education

Dr. Prakash received his foundational training in biochemistry and laboratory medicine, beginning his research career in 1993 as a Research Officer in Biochemistry at the Homoeopathic Drug Research Institute, Lucknow. He soon transitioned into forensic science and molecular diagnostics, working briefly at the Central Forensic Science Laboratory, Kolkata, before joining AIIMS in 1994. Over the years, he has continuously upgraded his scientific expertise through multidisciplinary collaborations and research leadership, particularly in the fields of molecular biology, clinical chemistry, and immunodiagnostics.

Research Focus

Dr. Prakash’s primary research interests span the molecular basis of liver and metabolic disorders, including non-alcoholic fatty liver disease (NAFLD), metabolic syndrome, and hepatitis B and C. He investigates the expression of tRNA-derived small RNAs, mitochondrial dysfunction, cytokine signaling, and nitric oxide pathways in chronic diseases. His lab has developed and validated micro-PCR technologies for rapid viral quantification (HBV, HCV, HIV), along with novel biosensors for anemia and salivary glucose detection. He is also involved in studying the role of micronutrients, vascular markers, and oxidative stress in gastrointestinal diseases and cancers.

Experience

Over the past three decades, Dr. Prakash has held several key positions. He joined AIIMS in 1994 as a Senior Scientist in the Department of Gastroenterology and Human Nutrition, where he served until 2014. He was then appointed Assistant Professor in the newly established Department of Laboratory Medicine, becoming Associate Professor in 2017 and Additional Professor in 2020. His earlier roles include Junior Scientific Officer at CFSL, Kolkata (1994), and Research Officer in Biochemistry at HDRI, Lucknow (1993–1994). This extensive experience has given him a deep understanding of both basic and applied biomedical science.

Research Timeline

Dr. Prakash’s research journey began in the early 1990s with clinical biochemistry and expanded into forensic and nutritional science. From 1994 to 2014, his work focused on gastrointestinal biology, where he contributed to understanding micronutrient deficiencies and inflammatory pathways in liver diseases. Since 2014, his research has evolved to include molecular diagnostics, small RNA profiling, oxidative stress biology, and biosensor technology. He now leads several national and collaborative projects funded by ICMR, DST, BIRAC, and AIIMS-IIT Delhi, focusing on advanced diagnostics for metabolic diseases and liver cancer.

Awards & Honors

Dr. Prakash is the recipient of numerous professional memberships and scientific honors. He is an Honorary Member of the Federation Internationale Law, Medicine, Ethics & Innovation (2024) and a Regular Member of the American Society for Biochemistry and Molecular Biology. He is also affiliated with the American Society of Cell Biology, Society for Free Radical Research, Indian Association of Biomedical Sciences, and the Society of Biological Chemists. His contributions have earned him positions on review panels for ICMR and DST, and he serves as a reviewer for the Indian Journal of Clinical Biochemistry and as a Board of Studies member at Poorvanchal University.

Top Noted Publication

Among his recent impactful publications is “Role of prokineticins and T-reg cells in obesity-associated metabolic oxidative dysregulation in NAFLD” (Scientific Reports, 2025), which provides insights into immune-metabolic interactions in liver disease. Another notable study, published in the IEEE Sensors Journal, presents a saliva-based non-invasive glucometer for diabetes management. He also co-authored a 2024 Sci Rep paper on HIV viral load quantification using micro-PCR, and contributed to landmark studies on anemia, PCOS, and biomarkers in metabolic and gastrointestinal diseases published in JAMA Netw Open, Lancet Regional Health, and MethodsX.

  1. Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
    JAMA Network Open, 2024, Vol. 7(10): 1–15
    Citations: 14
    A major population-based study under the PCOS Study Group (PSGS) exploring epidemiological and hormonal patterns among Indian women, with Dr. Prakash as a core contributor.

  2. Forced Convection Heat Transfer in Doubly Connected Ducts
    International Journal of Heat and Fluid Flow, 1987, Vol. 8(2): 107–110
    Citations: 14
    An early interdisciplinary engineering study co-authored by Dr. Prakash, contributing to thermal flow theory and heat transfer modeling.

  3. Prevalence of Sarcopenia and Its Determinants in People with Type 2 Diabetes
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2023, Vol. 17(12): 102902
    Citations: 13
    A collaborative clinical investigation identifying key predictors of muscle wasting in diabetic patients in northern India.

  4. Intravenous Iron Sucrose and Hematological Outcomes in Moderately Anemic Pregnant Women
    Indian Journal of Public Health, 2020, Vol. 64(1): 11–16
    Citations: 13
    This study measured changes in hemoglobin, ferritin, and oxidative stress biomarkers following iron therapy in pregnant women.

  5. Performance and Emission Characteristics of Diesel Engines Using Biodiesel from Safflower and Milk Scum Oil
    International Refereed Journal of Engineering and Science, 2014, Vol. 3(4): 103–112
    Citations: 13
    A cross-disciplinary energy study evaluating biodiesel alternatives for diesel engines, emphasizing Dr. Prakash’s early interest in environmental and engineering research.

  6. Takayasu’s Disease with Chest Pain, Fever, and Pleural Effusion
    Journal of the Association of Physicians of India, 2005, Vol. 53: 722–724
    Citations: 13
    A clinical case report on the diagnostic complexity of a rare vascular disease, illustrating Dr. Prakash’s broad medical expertise.

Dr. Shyam Prakash’s strength for the Healthcare Innovation Award:

1. Development of Affordable Point-of-Care Diagnostics
Dr. Prakash has led the innovation of low-cost, rapid diagnostic tools such as micro-PCR platforms for HBV, HCV, and HIV, and non-invasive biosensors for anemia and salivary glucose, making advanced diagnostics more accessible in resource-limited settings.

2. Translational Research in Liver and Metabolic Diseases
His work bridges lab science and clinical care through the discovery of molecular markers in NAFLD, hepatitis, and metabolic syndrome, including studies on small RNAs, oxidative stress, and cytokine pathways that enable early detection and targeted treatment.

3. Interdisciplinary Innovation and Engineering Collaboration
By integrating biomedical science with engineering, Dr. Prakash has co-developed novel sensor technologies and bio-analytical devices in partnership with institutes like IIT Delhi, demonstrating a strong track record in translational tech innovation.

4. Public Health Impact Through Large-Scale Clinical Research
He has contributed to major national studies on PCOS, sarcopenia, and anemia, translating research into real-world healthcare improvements and shaping public health strategies, particularly in women’s health and chronic disease management.

5. Leadership in Research and Mentorship
With over 30 years at AIIMS, Dr. Prakash has mentored 22+ MD/PhD scholars, led ICMR and DST-funded projects, and served on national review panels, establishing a legacy of academic leadership, innovation, and capacity building in Indian healthcare.

Muthaiah Muthuraj, Public Health, Best Innovator Award

Posted on by scizentox scizentoxLeave a Comment on Muthaiah Muthuraj, Public Health, Best Innovator Award

Dr. Muthaiah Muthuraj: Head of the Department,Department of Microbiology at Intermediate Reference Laboratory,Goernment Hospital for Chest Diseases, India

Dr. Muthaiah Muthuraj is a distinguished bacteriologist and the Head of the Department of Microbiology at the Government Hospital for Chest Diseases in India. With over 25 years of experience in academic training and research, he has made significant contributions to the study of tuberculosis (TB), particularly in the areas of drug resistance, molecular characterization of Mycobacterium tuberculosis, and the immunopathogenesis of TB meningitis. Dr. Muthuraj has been actively involved in various international TB research initiatives, including the Indo-US Regional Prospective Observational Research in TB (RePORT) project, and has published over 45 research articles in highly reputed national and international journals. His leadership extends beyond research; he is also a mentor for students at various levels, from MSc to Ph.D., and has authored three influential books on microbiology. He continues to play a critical role in advancing TB diagnostics and treatment strategies globally.

Online Profiles

Scopus Profile

Dr. Muthaiah Muthuraj is a seasoned bacteriologist and the Head of the Department at the Government Hospital for Chest Diseases, Puducherry, India. With a career spanning over 25 years, he has made significant contributions to the fields of microbiology and tuberculosis (TB) research. His extensive academic journey, which includes an M.Sc. in Microbiology, an M.Phil. in Biotechnology, and a Ph.D. in Biotechnology, has shaped his expertise in TB diagnostics, biomarkers, drug resistance, and the molecular characterization of Mycobacterium tuberculosis. Dr. Muthuraj has authored over 45 research articles, alongside several books and book chapters. His research has earned him recognition on international platforms, and his work is highly cited in scientific literature. He holds an h-index of 11 with 435 citations across 403 documents, a testament to the impact of his research in the scientific community. In addition to his academic and research contributions, Dr. Muthuraj serves as a co-investigator in several prestigious international studies, including the Indo-US Regional Prospective Observational Research on TB (RePORT). His commitment to advancing TB research and diagnostics is evident through his leadership in multiple research projects, awards, and honors throughout his distinguished career.

Education

Dr. Muthuraj’s academic journey began with an M.Sc. in Microbiology from Madurai Kamaraj University in 1992, where he gained a solid foundation in microbial sciences. He then pursued an M.Phil. in Biotechnology from Bharathidasan University in 2004, honing his skills in biotechnological applications. His doctoral research at Bharathiar University, completed in 2015, focused on the molecular aspects of tuberculosis and drug resistance. This combination of degrees has provided Dr. Muthuraj with a deep understanding of both the theoretical and practical aspects of microbiology and biotechnology, particularly as it applies to infectious diseases.

Research Focus

Dr. Muthuraj’s primary research interest lies in the molecular characterization of Mycobacterium tuberculosis and the identification of biomarkers that can improve TB diagnostics and treatment. His work on drug resistance mechanisms, especially in the context of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis, has garnered international attention. He is also exploring the immunopathogenesis of TB meningitis, a condition that poses significant diagnostic and therapeutic challenges. Additionally, Dr. Muthuraj is dedicated to developing innovative diagnostic tools, including CRISPR-based methods and molecular assays, as well as contributing to the development of new vaccines and drug therapies for TB.

Experience

Dr. Muthuraj’s career spans both academic and industrial domains. He began his career in the pharmaceutical industry, holding senior roles at Zydus Cadila Pharmaceuticals and Spic Pharmaceuticals, where he contributed to vaccine production and microbiological testing. In 2000, he transitioned to his current academic role, becoming the Head of the Microbiology Department at the Government Hospital for Chest Diseases. He oversees the TB diagnostics laboratory, which plays a key role in regional TB control and research. In addition to his clinical and research responsibilities, Dr. Muthuraj is an active mentor for graduate and doctoral students, guiding them through research projects and providing academic leadership.

Research Timeline

Dr. Muthuraj’s research career began in the 1990s, focusing initially on microbiological techniques for vaccine production. By the early 2000s, his research pivoted to the study of tuberculosis, specifically targeting M. tuberculosis and TB drug resistance. Over the years, his research has grown to encompass various aspects of TB biology, diagnostics, and treatment, with an increasing focus on molecular biology and immunology. His involvement in the RePORT initiative in India and his role as a co-investigator in several NIH-funded studies reflect his ongoing commitment to understanding TB at the molecular and clinical levels. His research continues to address critical gaps in TB diagnostics and management, particularly for drug-resistant forms of the disease.

Awards & Honors

Dr. Muthuraj has received numerous honors for his contributions to the field of microbiology. His editorial and peer review roles for top-tier journals, such as Nature, Lancet, and Elsevier, are a testament to his expertise and influence in the scientific community. He has also been recognized by international organizations for his work in TB research, particularly for his role in advancing diagnostic methods and studying the molecular underpinnings of drug resistance. His achievements have led to his involvement in global TB initiatives and recognition as a leading expert in the field.

Recent Publication

One of Dr. Muthuraj’s most recent publications, Prevalence of Extrapulmonary Tuberculosis and Factors Influencing Successful Treatment Outcomes (published in Scientific Reports in 2025), addresses the growing concern of extrapulmonary tuberculosis (EPTB) in South India. His research explores the factors influencing treatment outcomes in EPTB cases, providing valuable data that could inform better diagnostic and therapeutic approaches. This study, along with several others published in BMC Infectious Diseases and Current Microbiology, demonstrates Dr. Muthuraj’s continued commitment to improving TB treatment outcomes and understanding the complexities of the disease. His work is frequently cited by other researchers, furthering the impact of his findings in the global scientific community.

  1. Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis

    • Journal: BMC Infectious Diseases, 2025

    • Overview: This article explores the correlation between mutations in the rpoB gene and varying levels of Rifampicin resistance in Mycobacterium tuberculosis, providing insight into how these factors influence treatment outcomes in Rifampicin-resistant TB.

  2. Prevalence of extrapulmonary tuberculosis and factors influencing successful treatment outcomes among notified cases in South India

    • Journal: Scientific Reports, 2025

    • Overview: This study investigates the prevalence of extrapulmonary tuberculosis (TB) in South India and the various factors that impact the success of treatment for these cases, shedding light on regional trends and treatment challenges.

  3. Evaluation of Tridax procumbens Secondary Metabolites Anti-Tuberculosis Activity by In Vitro and In Silico Methods

    • Journal: Current Microbiology, 2025

    • Citations: 3

    • Overview: This article evaluates the anti-tuberculosis activity of secondary metabolites derived from Tridax procumbens using both laboratory-based in vitro methods and computational in silico analyses, potentially identifying new therapeutic agents for TB treatment.

Strength for the Best Innovator Award

For the Best Innovator Award, Dr. Muthaiah Muthuraj’s strengths can be showcased through the following five key topics where his innovative contributions stand out:

1. Molecular Characterization of Mycobacterium tuberculosis

  • Innovation: Dr. Muthuraj pioneered novel molecular techniques for identifying drug-resistant strains of Mycobacterium tuberculosis. His work in understanding genetic mutations, especially in the rpoB gene, has significantly advanced TB diagnostics.

  • Impact: His research has improved the accuracy of TB detection, enabling more effective treatment strategies, especially in drug-resistant TB cases.

2. Development of CRISPR-based TB Diagnostics

  • Innovation: Dr. Muthuraj has been a key figure in developing CRISPR-based diagnostic methods for tuberculosis, allowing for rapid and precise detection of TB and drug resistance markers.

  • Impact: This groundbreaking work offers a more affordable, portable, and scalable solution to TB diagnosis, which is crucial in resource-limited regions.

3. Extrapulmonary Tuberculosis (EPTB) Research

  • Innovation: His research on EPTB, particularly in South India, has identified key factors influencing successful treatment outcomes, contributing to improved management strategies for this often-overlooked form of TB.

  • Impact: This work is helping to reshape how TB is managed outside of the lungs, influencing clinical practices and policy on a global scale.

4. Natural Product-Based Anti-Tuberculosis Agents

  • Innovation: Dr. Muthuraj’s work in exploring the anti-tuberculosis potential of secondary metabolites from plants like Tridax procumbens is a pioneering approach to discovering alternative TB treatments.

  • Impact: This research is helping to diversify the drug pipeline for TB, providing new, potentially less toxic options for treatment.

5. Immunopathogenesis of TB Meningitis

  • Innovation: Dr. Muthuraj has contributed to groundbreaking studies on the immunological mechanisms behind TB meningitis, focusing on novel molecular and immune markers.

  • Impact: His findings are crucial for the development of better therapeutic strategies for TB meningitis, a condition that is difficult to diagnose and treat effectively.

Chunyi Fang, Public Health, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Chunyi Fang, Public Health, Best Researcher Award

Dr. Chunyi Fang: Physical therapist at Zhejiang Provincial People’s Hospital, China

Dr. Chunyi Fang is a medical doctor and clinical researcher with a strong academic background in rehabilitation therapy and pediatric exercise science. She is affiliated with the Center for Rehabilitation Medicine at Zhejiang Provincial People’s Hospital, one of China’s leading centers for rehabilitation research. Her work primarily focuses on pediatric physical activity, exploring how movement behaviors influence physical fitness and health outcomes in preschool-aged children. With both domestic and international publications, Dr. Fang has developed a reputation for combining clinical insight with rigorous data analysis, contributing to early childhood health promotion and rehabilitation strategies.

Online Profiles

ORCID Profile

Education

Dr. Fang earned her M.D. in 2017 from Shanghai University of Sport, where she conducted original research on how daily step counts influence cardiovascular and muscular fitness in preschoolers—an area that laid the groundwork for her later publications. Prior to that, she completed her Bachelor of Science degree in Rehabilitation Therapy at North China University of Science and Technology in 2012. Her academic path reflects a steady focus on clinical rehabilitation and the development of functional health in children, combining both practical and scientific approaches.

Research Focus

Her research concentrates on pediatric physical fitness, particularly examining how different types and intensities of physical activity and sedentary behavior affect developmental health outcomes. Using advanced tools such as accelerometers, she quantifies daily activity levels and links them to cardiovascular, neuromuscular, and motor skill indicators in young children. Dr. Fang’s work is especially known for addressing dose-response relationships, investigating how varying movement patterns correspond to health benchmarks in preschool-aged populations. She also contributes to cluster-based analyses and early intervention planning.

Experience

Dr. Fang currently works at the Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, where she plays a key role in research design, data collection, and clinical application. She has contributed to both observational studies and experimental trials involving child development, physical activity measurement, and rehabilitation protocols. She also assists in training clinical staff in pediatric assessments and collaborates with physicians, therapists, and data scientists in large-scale health studies. Her role bridges the gap between academic theory and hands-on clinical practice.

Research Timeline

Beginning in 2017, Dr. Fang’s early work investigated fundamental relationships between movement and fitness in young children. Her first notable international publication appeared in the Journal of Clinical Medicine in 2020, followed by co-authored studies in Frontiers in Pediatrics and Scientific Reports. From 2020 to 2025, she expanded her research methods to include wearable technology, sedentary behavior modeling, and cross-sectional studies with large preschool cohorts. She continues to participate in national and international collaborations while mentoring new researchers in pediatric rehabilitation.

Awards & Honors

While specific awards are not listed, Dr. Fang’s research has received recognition through publication in high-impact journals and citation by leading scholars in physical education and pediatric medicine. Her work was selected for publication in Scientific Reports and Frontiers in Human Neuroscience, reflecting both methodological quality and relevance to public health. She has also received internal commendations from Zhejiang Provincial People’s Hospital for her contributions to evidence-based rehabilitation practice and collaborative research excellence.

Top-Noted Publication

Her most cited and prominent paper is: Fang C, Li L, Jin Z, He C, Liang F, Ye X, Lu Y, Quan M. (2025). Accelerometer-Based Independent and Combined Associations of Physical Activity and Sedentary Time on Physical Fitness in Preschool Children: A Cross-Sectional Study. Published in Scientific Reports, this study offers a comprehensive look at how objectively measured physical activity and inactivity are related to fitness outcomes in early childhood. It emphasizes the importance of reducing sedentary time and encouraging moderate-to-vigorous activity for promoting children’s health.
DOI: https://doi.org/10.1038/s41598-025-00626-x

Fang C, Li L, Jin Z, He C, Liang F, Ye X, Lu Y, Quan M. (2025). Accelerometer-Based Independent and Combined Associations of Physical Activity and Sedentary Time on Physical Fitness in Preschool Children: A Cross-Sectional Study. Scientific Reports, 15(1):26691.
DOI: 10.1038/s41598-025-00626-x
This study explored the independent and joint effects of physical activity and sedentary time on health-related fitness using objective accelerometer data in preschoolers.

Fang C, Zhang J, Zhou T, Li L, Lu Y, Gao Z, Quan M. (2020). Associations between Daily Step Counts and Physical Fitness in Preschool Children. Journal of Clinical Medicine, 9(1):163.
DOI: 10.3390/jcm9010163
Among the first studies to examine the dose-response association between step count and physical fitness in children aged 3–6, this article provides foundational evidence supporting active lifestyle promotion in early childhood.

Liu J, Li Y, Zhou T, Lu Y, Sang M, Li L, Fang C, Hu W, Sun X, Quan M. (2022). Relationship Between Gross Motor Skills and Inhibitory Control in Preschool Children: A Pilot Study. Frontiers in Human Neuroscience, 16:848230.
DOI: 10.3389/fnhum.2022.848230
This pilot study evaluated the cognitive-motor link in preschoolers, finding significant associations between gross motor competence and inhibitory control, a critical executive function.

Lu Y, Li Y, Zhou T, Sang M, Li L, Fang C, Hu W, Quan M. (2022). The Association of Different Sedentary Patterns and Health-Related Physical Fitness in Pre-schoolers. Frontiers in Pediatrics, 9:796417.
DOI: 10.3389/fped.2021.796417
This paper examined how various sedentary behavior patterns relate to fitness metrics in preschool children, revealing that prolonged sedentary bouts are negatively associated with cardiovascular and muscular fitness.

Khadija Daoud, Public Health, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Khadija Daoud, Public Health, Best Researcher Award

Doctorate Khadija Daoud: Phd Student at Sciences and Engineering of Biomedicals, Biophysics and Health Laboratory, Higher Institute of Health Sciences, Hassan First University, Settat, Morocco

Khadija Daoudi is a dedicated PhD candidate in Health Sciences at the Higher Institute of Health Sciences – Hassan, with a strong foundation in nursing sciences and health education. She specializes in analyzing communication patterns within health education sessions to improve interaction between educators and students, ultimately enhancing health literacy and patient care. Khadija combines her research expertise with practical teaching experience, demonstrating leadership, resilience, and a commitment to advancing health education in Morocco and beyond. Her multidisciplinary approach integrates analytical thinking and interpersonal skills to address real-world healthcare challenges.

Online Profiles

ORCID Profile

Khadija Daoudi is affiliated with Université Hassan 1er, Settat, Morocco. She is registered on Scopus under ID 59152670500 and has an ORCID profile (0009-0003-3220-6492) that catalogs her research output. Her academic work includes 3 published documents, which have been cited 6 times, resulting in an h-index of 1. Khadija’s research profile is also connected to Mendeley, providing further access to her publications and collaborations within the academic community.

Education

Khadija earned her Bachelor’s Degree in Nursing Sciences from the Higher Institute of Health Sciences – Settat, equipping her with both theoretical knowledge and practical clinical skills. She is currently pursuing a PhD in Health Sciences at the Higher Institute of Health Sciences – Hassan, where she focuses on interaction analysis in health education settings. Prior to this, she completed her Baccalaureate with honors in the Science Track, demonstrating a strong academic foundation and commitment to scientific research from an early stage in her education.

Research Focus

Her research centers on the psychometric evaluation and application of the Roter Interaction Analysis System (RIAS) in Moroccan health education contexts, aiming to better understand communication dynamics between educators and students. She investigates how these interactions influence health education outcomes and behavior change. Additionally, Khadija explores the role of advanced nursing practice in palliative care, conducting rapid reviews to identify best practices and improve patient care delivery. Her work bridges the gap between communication theory and healthcare practice.

Experience

Since 2018, Khadija has worked as a teacher under the Ministry of National Education in the Province of Settat, Morocco. In this capacity, she delivers health education, develops curricula, and fosters effective communication skills among students. Her teaching approach is enriched by her multilingual abilities: she is a native Arabic speaker and proficient in French and English (both at C1 level), with intermediate proficiency in Spanish (B1). This linguistic versatility enables her to engage a diverse student body and adapt educational content to varied audiences.

Research Timeline

Khadija’s research trajectory includes several key scholarly contributions. In 2024, she published a scoping review on educator-student communication patterns in health education, followed by a rapid review on advancing palliative care through advanced nursing practice. Her most recent publication in 2025 focuses on the psychometric properties of the Roter Interaction Analysis System within Moroccan schools, reflecting her ongoing commitment to enhancing health communication research. These publications highlight her consistent academic productivity throughout her doctoral studies.

Awards & Honors

Throughout her academic career, Khadija has consistently demonstrated excellence, graduating with honors in her Baccalaureate Science Track. Her research has been recognized through multiple peer-reviewed journal publications, establishing her reputation as a dedicated and impactful scholar in health sciences. She continues to strive for academic and professional excellence, contributing valuable insights to health education and nursing practice research in Morocco and internationally.

Top-Noted Publication

One of Khadija’s most significant works is “Psychometric characteristics of Roter Interaction Analysis System (RIAS) in the context of health education in a Moroccan school,” published in PEC Innovation in 2025. Co-authored with Khaoula Jounaidi and Abdellah Gantare, this study evaluates the reliability and validity of RIAS as a communication assessment tool in Moroccan health education settings. The publication has important implications for improving educator training and patient communication strategies, offering a culturally relevant perspective that enhances health education effectiveness in Morocco and similar contexts.

Top-Noted Publication

Khadija’s landmark publication, “Psychometric characteristics of Roter interaction analysis system (RIAS) in the context of health education in a Moroccan school,” published in PEC Innovation in 2025, offers critical validation of an established communication analysis tool within a unique cultural context. This work has significant implications for improving health educator training and optimizing communication strategies to enhance patient outcomes in Morocco and similar settings.

  • Psychometric characteristics of Roter Interaction Analysis System (RIAS) in the context of health education in a Moroccan school

    • Journal: PEC Innovation

    • Date: June 2025

    • DOI: 10.1016/j.pecinn.2025.100403

    • ISSN: 2772-6282

    • Contributors: Khadija Daoudi, Khaoula Jounaidi, Abdellah Gantare

  • Advancing Palliative Care through Advanced Nursing Practice: A Rapid Review

    • Journal: Indian Journal of Palliative Care

    • Date: 2024

    • DOI: 10.25259/IJPC_308_2023

    • ISSN: 1998-3735, 0973-1075

    • Contributors: K. Jounaidi, M. Hamdoune, K. Daoudi, N. Barka, A. Gantare

  • Exploring Educator-Student Communication Patterns in Health Education Settings: A Scoping Review

    • Journal: Pakistan Journal of Life and Social Sciences

    • Date: 2024

    • DOI: 10.57239/PJLSS-2024-22.1.00375

    • ISSN: 2221-7630, 1727-4915

    • Contributors: Khadija Daoudi, Abdellah Gantare

Xuemei Xie, Public Health, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Xuemei Xie, Public Health, Best Researcher Award

Doctorate Xuemei Xie: Assistant Professor at University of Hawaii Cancer Center, United States

Dr. Xuemei Xie is a cancer biologist and translational oncology researcher currently serving as an Assistant Professor in the Cancer Biology Program at the University of Hawai‘i Cancer Center. With a research career spanning over two decades across China, Canada, and the United States, she has developed an internationally recognized profile in aggressive breast cancer research, particularly in triple-negative breast cancer (TNBC) and inflammatory breast cancer. Her work bridges basic science and clinical translation, focusing on the tumor microenvironment, signal transduction pathways, and novel therapeutic strategies. Through extensive collaborations, grant-funded projects, and impactful publications, Dr. Xie has established herself as a leading voice in breast cancer translational research.

Online Profiles

ORCID Profile

Dr. Xie maintains an active academic presence through several professional and scholarly platforms. Her Google Scholar profile tracks over 50 peer-reviewed publications in oncology and immunology, while her ResearchGate profile shares research updates, project summaries, and full-text access. She also contributes to editorial and peer review efforts for leading journals such as Cancer Immunology, Immunotherapy, Biomedicines, and Frontiers in Medicine. Additionally, she may be listed on her institutional faculty page at the University of Hawai‘i Cancer Center and may maintain a presence on LinkedIn for networking and academic outreach.

Education

Dr. Xie received her foundational training in biology with a B.Sc. in Zoology from Lanzhou University in China (1988–1992). She later pursued advanced graduate studies in Canada, earning her M.Sc. in Reproductive Immunology at the University of Guelph (2002–2004), where she focused on murine immune cell function during pregnancy. She continued her doctoral research at the same institution in Recombinant Antibody Engineering Technology (2004–2009), with her Ph.D. research funded by competitive Canadian scholarships including the NSERC Canada Graduate Scholarship D. She then completed a prestigious postdoctoral fellowship at The University of Texas MD Anderson Cancer Center, where she specialized in breast and ovarian cancer biology.

Research Focus

Dr. Xie’s research centers on understanding and targeting key signaling pathways and immune mechanisms that promote tumor progression, metastasis, and therapy resistance in breast cancer. She is particularly focused on the immunosuppressive role of the JNK pathway in the tumor microenvironment, and how it drives immune evasion in TNBC. Her team investigates targeted therapies, including immunoproteasome inhibitors, CDK7 and androgen receptor inhibitors, and antibody-drug conjugates. Her work also integrates pharmacologic, transcriptomic, and immunologic methods to identify synergistic drug combinations and predictive biomarkers, with the long-term goal of advancing personalized therapy for breast cancer patients.

Experience

Dr. Xie brings a rich combination of academic and industry experience. She began her career as a faculty member in the Department of Biology at Qinghai Normal University, then transitioned to biomedical research in Canada and the U.S. She spent over a decade at MD Anderson Cancer Center in roles ranging from postdoctoral fellow to senior research scientist, leading preclinical projects and mentoring trainees. In the biotech sector, she served as Principal Scientist and Director of Oncology and Pharmacology at Wuhan YZY Biopharma, where she led immunotherapy programs and contributed to FDA IND applications. In 2023, she joined the University of Hawai‘i Cancer Center as Assistant Professor, launching her independent research program on TNBC.

Research Timeline

Dr. Xie’s scientific career spans more than 30 years and reflects a continuous evolution in cancer research. Between 1992 and 1999, she taught and conducted reproductive ecology research in China. From 2002 to 2009, she conducted graduate and doctoral research in immunology and antibody engineering in Canada. From 2010 to 2023, she held research appointments at MD Anderson Cancer Center, contributing significantly to preclinical therapeutic development. Her recent transition to faculty leadership at the University of Hawai‘i Cancer Center in 2023 marked the launch of her NIH R01-funded independent lab focused on immunomodulatory therapies in breast cancer.

Awards & Honors

Dr. Xie has been widely recognized for her scientific contributions and mentoring excellence. Her accolades include the 1st Prize Poster Award at the 2025 International Workshop on Inflammatory Breast Cancer in Tunisia, the 2021 Zeta Tau Alpha (ZTA) Fellowship Award at MD Anderson, and multiple Employee Performance Awards for research excellence. She is also a past recipient of the Susan G. Komen Postdoctoral Fellowship and NSERC Canada Scholarships. Her consistent recognition—from early academic scholarships to competitive international research grants—underscores her sustained impact in oncology research and her commitment to scientific advancement.

Top-Noted Publication

Among her many influential publications, one of the most impactful is: Xie X, et al. Targeting CDK7 enhances the antitumor efficacy of enzalutamide in androgen receptor-positive triple-negative breast cancer by inhibiting c-MYC-mediated tumorigenesis. Molecular Cancer Therapeutics (2025); 24(6):870–883. This study identified a promising strategy for overcoming resistance to androgen receptor inhibitors by dual-targeting CDK7, providing a foundation for future clinical trials. The work is notable for its mechanistic depth and translational relevance, marking a key advancement in targeted therapy for a challenging breast cancer subtype.

  • Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-MYC–mediated Tumorigenesis

    • Type: Preprint

    • Date: 2025-06-04

    • DOI: 10.1158/1535-7163.c.7856556

    • Contributors: Xuemei Xie, Maroua Manai, Dileep R. Rampa, Jon A. Fuson, Elizabeth S. Nakasone, Troy Pearson, Bharat S. Kuntal, Debu Tripathy, Naoto T. Ueno, Jangsoon Lee

    • Source: Crossref

  • LMP7-Specific Inhibitor M3258 Modulates the Tumor Microenvironment of Triple-Negative Breast Cancer and Inflammatory Breast Cancer

    • Type: Journal article

    • Date: 2025-06-04

    • DOI: 10.3390/cancers17111887

    • Contributors: Xuemei Xie, Jangsoon Lee, Ganiraju C. Manyam, Troy Pearson, Gina Walter-Bausch, Manja Friese-Hamim, Sheng Zhao, Julia Jabs, Angela A. Manginelli, Nadine Piske et al.

    • Source: Crossref

  • Supplementary Figure S1 from Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer

    • Type: Preprint Supplementary

    • Date: 2025-06-04

    • DOI: 10.1158/1535-7163.29234055

    • Contributors: Same as main preprint

    • Source: Crossref

  • Supplementary Figure S2 from Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer

    • Type: Preprint Supplementary

    • Date: 2025-06-04

    • DOI: 10.1158/1535-7163.29234052

    • Contributors: Same as main preprint

    • Source: Crossref

  • Supplementary Figure S3 from Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer

    • Type: Preprint Supplementary

    • Date: 2025-06-04

    • DOI: 10.1158/1535-7163.29234049

    • Contributors: Same as main preprint

    • Source: Crossref